PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.07%
Revenue growth under 50% of AVGO's 9.28%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
6.28%
Gross profit growth at 50-75% of AVGO's 10.51%. Martin Whitman would question if cost structure or brand is lagging.
8.28%
EBIT growth below 50% of AVGO's 21.40%. Michael Burry would suspect deeper competitive or cost structure issues.
8.59%
Operating income growth under 50% of AVGO's 21.40%. Michael Burry would be concerned about deeper cost or sales issues.
9.81%
Net income growth above 1.5x AVGO's 6.02%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
9.48%
EPS growth above 1.5x AVGO's 4.55%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
9.66%
Diluted EPS growth above 1.5x AVGO's 4.76%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.11%
Share reduction more than 1.5x AVGO's 0.24%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
12.62%
Dividend growth above 1.5x AVGO's 0.08%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-2.92%
Negative OCF growth while AVGO is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-44.64%
Negative FCF growth while AVGO is at 0.79%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
73.70%
10Y revenue/share CAGR under 50% of AVGO's 605.24%. Michael Burry would suspect a lasting competitive disadvantage.
52.56%
5Y revenue/share CAGR at 50-75% of AVGO's 72.57%. Martin Whitman would worry about a lagging mid-term growth trajectory.
34.08%
3Y revenue/share CAGR similar to AVGO's 35.72%. Walter Schloss would assume both companies experience comparable short-term cycles.
198.43%
10Y OCF/share CAGR under 50% of AVGO's 977.14%. Michael Burry would worry about a persistent underperformance in cash creation.
83.17%
5Y OCF/share CAGR at 50-75% of AVGO's 152.38%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
13.33%
3Y OCF/share CAGR under 50% of AVGO's 34.05%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
782.06%
Net income/share CAGR 1.25-1.5x AVGO's 666.12%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
120.11%
Below 50% of AVGO's 403.26%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
77.97%
3Y net income/share CAGR similar to AVGO's 77.94%. Walter Schloss would attribute it to shared growth factors or demand patterns.
49.67%
Below 50% of AVGO's 638.92%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
37.23%
5Y equity/share CAGR 1.25-1.5x AVGO's 27.46%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
52.90%
Positive short-term equity growth while AVGO is negative. John Neff sees a strong advantage in near-term net worth buildup.
576.51%
Below 50% of AVGO's 3329.42%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
129.41%
Below 50% of AVGO's 606.19%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
48.82%
Below 50% of AVGO's 115.37%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
2.90%
Our AR growth while AVGO is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
2.52%
Inventory shrinking or stable vs. AVGO's 11.81%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
6.03%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
9.61%
BV/share growth above 1.5x AVGO's 2.30%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
6.03%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.26%
We increase R&D while AVGO cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-1.94%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.